|Articles|December 1, 2022

Self-tonometry provides invaluable insights into IOP fluctuations

Advertorial: Self-tonometry provides invaluable insights into IOP fluctuations

A recent study by Tong et al.1 highlights that IOP profiles obtained using the iCare HOME self-tonometer, may reflect IOP responses to treatment more accurately than standard IOP measurements in the office. This more comprehensive understanding of IOP fluctuations offers the eye care professional valuable support in making glaucoma management decisions.

Don’t miss out—get Modern Retina updates delivered straight to your inbox.

Self-tonometry provides invaluable insights into IOP fluctuations

Related Content

EYLEA 8mg in RVO: QUASAR clinical perspectives video

EYLEA 8mg in RVO: snapshot of the 64-week QUASAR data

Propelling R&D for Novel Retinal Therapies Through Innovative Clinical Trial Design

Could targeting retinal non-perfusion be the key to achieving true disease modification in diabetic retinopathy?

Real World insights with EYLEA 8mg

Latest CME

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

MacTel Decoded: Rethinking Conventional Approaches With Novel Neuroprotective Strategies

Treatment Optimization in the Evolving Anti-VEGF Era

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

(COPE) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

(CME Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

(COPE Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

(CME Track) Cutting-Edge Care in Neovascular Retinal Disease: Expert Approaches to Selection and Interval Extension

(COPE Track) Next-Generation Solutions for nAMD and DME: Bridging Evidence and Practice Gaps in Disease Management

(COPE Track) Emerging Therapeutic Advancements in Dry Eye Disease Management

Trending on Eye Care Network - Ophthalmology Times

Retinal imaging as a window into atrial fibrillation

The Wills Retina Report: Mapping gene therapy for wet AMD with Carl D. Regillo, MD, and Allen C. Ho, MD

Think outside the cone: Applying the Gulani Keratoconus Classification

OCT-980 receives FDA orphan drug designation for retinitis pigmentosa

Johnson & Johnson spotlights contrast data, 1 million TECNIS implants, and SmartLOAD delivery